← Back to Clinical Trials
Recruiting NCT06889519

NCT06889519 Lighthouse Parenting Nanai: a Mentalization-based Group Therapy for Caregivers with History of Trauma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06889519
Status Recruiting
Phase
Sponsor University Diego Portales
Condition Child Maltreatment
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-08-17
Primary Completion 2025-05-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
MBT Lighthouse Parenting ProgramPsychoeducational cards

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-08-17 with a primary completion date of 2025-05-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this feasibility randomized controlled trial is to evaluate the effectiveness and acceptability of the Lighthouse Mentalization-Based Treatment Parenting Program (Lighthouse MBT-P) as an intervention for parents at risk of maltreating their children. The study focuses on parents with a history of childhood trauma, aiming to improve parent-child relationships, reduce parenting stress, and ultimately decrease the risk of child maltreatment. The goal of this study is to test how well the Lighthouse Mentalization-Based Treatment Parenting Program (Lighthouse MBT-P) works for parents who may be at risk of harming their children. The program aims to help parents understand and manage their own and their children's emotions better. By improving these skills, the program hopes to reduce stress in parenting and lower the chances of child abuse or neglect. The main questions this study will answer are: * Can parents follow and complete the Lighthouse MBT-P program? * Does the program help lower stress in parenting and improve relationships between parents and their children? Participants in this study will: * Attend weekly group sessions for 12 weeks. These sessions will teach them how to better understand and manage emotions. * Take part in discussions led by trained psychologists. Researchers will compare the results of parents who take part in the Lighthouse MBT-P program with those who receive standard parenting support to see which approach works better.

Eligibility Criteria

Inclusion Criteria: 1. Biological parents of children (0-36 months old) with custody of their child. 2. Parents who have gone through adverse childhood experiences, have a history of parental substance abuse or incarceration, have current exposure to relationship violence, or social isolation, or have lost custody of a child in the past. 3. Parents must be over the age of 18. Exclusion Criteria: 1. Parents who are unable to provide informed consent due to mental or cognitive impairment, 2. Parents not fluent in Spanish. 3. Child's diagnosis of autistic spectrum disorder or severe cognitive delay.

Contact & Investigator

Central Contact

Stefanella Costa Cordella, PhD

✉ costacordella@gmail.com

📞 800-555-5555

Frequently Asked Questions

Who can join the NCT06889519 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Child Maltreatment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06889519 currently recruiting?

Yes, NCT06889519 is actively recruiting participants. Contact the research team at costacordella@gmail.com for enrollment information.

Where is the NCT06889519 trial being conducted?

This trial is being conducted at Santiago, Chile.

Who is sponsoring the NCT06889519 clinical trial?

NCT06889519 is sponsored by University Diego Portales. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology